On April 22, 2020 Immunovia reported that invites to a teleconference (in English) for investors, analysts and media on Tuesday, April 28th, 2020 at 16:30 CET (Press release, Immunovia, APR 22, 2020, View Source;march-2020-on-april-28-2020-301045422.html [SID1234556511]). Immunovia will publish the company’s interim report on April 28th, 2020 at 16:00 CET.

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Mats Grahn, CEO will present Immunovia and comment on the interim report for the period January – March 2020 followed by a Q&A session.

Please call in a few minutes in advance. To attend, please dial-in at one of the numbers below and provide the conference code Immunovia to the operator:

Immunovia Webcast: https://channel.royalcast.com/webcast/immunovia/20200401_1/

There will be an MP3-file available at Immunovia’s webpage under Investors/Financial Reports (View Source) for those who want to listen to the telephone conference afterwards. The file will be available within two hours after the conference has ended.